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A B S T R A C T
Achromobacter xylosoxidans is an aerobic, nonfermenting gram-negative rod and described as a
waterborne bacterium since it habits aquatic environments ubiquitously. It has frequently been isolated
from aquatic surroundings in the hospital and from various human body sites. Although occasionally
considered a non-pathogen, A. xylosoxidans has been associated with outbreaks of nosocomial infection
due to contaminated ﬂuids. Moreover, a wide variety of infectious etiologies due to A. xylosoxidans has
been reported primarily in immunocompromised individuals. Heightened awareness of this bacterium
and associated clinical importance is warranted for clinicians since its broad disease spectrum in humans
and frequent multi-drug resistance may result in an increased mortality rate. In this report, we describe a
case of osteomyelitis caused by A. xylosoxidans in a patient with a history of diabetes mellitus.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Achromobacter xylosoxidans is an aerobic, motile, nonferment-
ing gram-negative rod. It was ﬁrst isolated from patients with
chronic otitis media in 1971 [1]. A. xylosoxidans inhabits aquatic
environments ubiquitously and it has been implicated in outbreaks
related to contaminated ﬂuids in the hospital. It has also been
recovered from various human body ﬂuids, including respiratory
tract secretions and peritoneal ﬂuid. Although a broad range of
infectious etiologies due to A. xylosoxidans have been described in
the literature primarily in immunocompromised hosts, it has
rarely been reported as a cause of osteomyelitis. We herein report a
case of osteomyelitis caused by A. xylosoxidans.
Case report
A 39-year-old male with a longstanding history of diabetes
mellitus was in his usual status until 7 days prior to presentation
when he developed severe pain in his left great toe. The pain was
described as throbbing, progressive in nature, and associated with
subjective fevers and malaise. He had noticed ulceration with an
open wound on the left great toe 3 months before. Serosanguinous
discharge and foul-smelling were also observed. He was noncom-
pliant with his insulin therapy. On physical examination, the* Corresponding author at: Department of Pathology, Microbiology and
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4.0/).patient appeared ill. The temperature was 102.1 8F, blood pressure
91/58 mm Hg, pulse 134 beats per minute, respirations 19 breaths
per minute and oxygen saturation 98% on room air. His heart
sounds revealed tachycardia without murmurs and his lungs were
clear to auscultation. There was deep ulceration with an open
wound on his great toe with surrounding erythema and edema.
Serosanguinous discharge was observed and marked tenderness
was elicited on the surrounding erythema. Laboratory studies
revealed a white blood cell count of 19,100 cells/mm3 with 68%
polymorphonuclear leukocytes, hemoglobin of 12.3 g/dL, and
platelets of 281,000 per cubic millimeter. The level of sodium
was 126 mmol/L, potassium 4.3 mmol/L, bicarbonate 22 mEq/L,
urea nitrogen 20 mg/dL, creatinine 1.2 mg/dL, and lactic acid
5.1 mg/dL. A magnetic resonance imaging (MRI) study disclosed
extensive bony destruction of his left great toe with surrounding
soft tissue edema, ﬁndings compatible with osteomyelitis.
Subsequently, the patient underwent amputation of the infected
left great toe. The pathological examination of the infected bone
revealed multiple fragments of dead bone with inﬁltrating plasma
cells consistent with chronic osteomyelitis. Cultures of the bone
yielded A. xylosoxidans. The initial empiric antimicrobial therapy
with vancomycin was changed to piperacillin/tazobactam based
on the antimicrobial susceptibility results. There were no signs of
recurrence on a follow-up MRI study 6 weeks later.
Discussion
A. xylosoxidans was ﬁrst isolated from ear discharge of patients
with chronic otitis media [1]. The organism has been furthere under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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ing gram-negative rod with distinctive biochemical characteristics.
It has oxidase and catalase activity and oxidizes glucose and xylose.
It is motile by peritrichous ﬂagella, which aids differentiate it from
other nonfermenters [2]. A. xylosoxidans has the ability to survive in
aqueous environments and as such, it can be a cause of nosocomial
outbreaks especially when there is a breakdown of infectious
control techniques. In fact, since it was ﬁrst described in 1971 [1], it
has been associated with numerous outbreaks due to contaminat-
ed ﬂuids as well as other invasive nosocomial infections, such as
catheter-related bacteremia [3,4]. Except in nosocomial outbreaks,
immunocompromised individuals are particularly at increased
risk for developing severe infection due to A. xylosoxidans. In a
review of 77 cases of bacteremia due to A. xylosoxidans by Duggan
et al., 30% had an underlying malignancy (30%) [5]. Although
bacteremia is the most frequently reported infection associated
with A. xylosoxidans, a wide variety of other clinical manifestations
have also been reported, including peritonitis [6], pneumonia [7],
and prosthetic joint infection [8]. In 1991, osteomyelitis due to A.
xylosoxidans was descried in a child who developed a plantar
puncture wound [9]. Since then, only a small number of case
reports of A. xylosoxidans osteomyelitis have been described in the
literature [10,11]. Our patient developed osteomyelitis potentially
in direct contact with A. xylosoxidans in the presence of impaired
defense system due to his longstanding uncontrolled diabetes
mellitus. A. xylosoxidans is resistant to multiple antibiotics,
including cefoxitin, ceftriaxone, cefotaxime, aztreonam, and
aminoglycosides. It is usually susceptible to trimethoprim-
sulfamethoxazole, antipseudomonal penicillins, ceftazidime, cefo-
perazone, and carbapenems [5,12]. Our patient was successfully
treated with piperacillin/tazobactam. Beta-lactamase inhibitor
combinations are also generally effective antimicrobials against A.
xylosoxidans [13].
Conclusions
We reported a case of osteomyelitis caused by A. xylosoxidans in
a patient with diabetes mellitus. A. xylosoxidans is ubiquitous in
aquatic environments, thus it has caused numerous nosocomial
outbreaks due to contaminated ﬂuids. It has also been associated
with a wide array of infectious etiologies primarily in immuno-
compromised individuals. Additionally, multi-drug resistance
is not rare for this bacterium. Heightened awareness of its
pathogenic potential is paramount, though osteomyelitis causedby A. xylosoxidans is not a common clinical entity among the broad
disease spectrum of A. xylosoxidans.
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
this journal on request.
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